Approval · Notice of Compliance 166 · 2004
SONOVUE: Notice of Compliance 166
Issued February 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 166
- Date
- February 12, 2004
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Diagnostic ultrasound contrast agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SONOVUE | 02248152 | — |
Medicinal ingredients
- SULFUR HEXAFLUORIDE 8 MCL per ML